Sorrento Therapeutics, Inc. - FORM 10-K - EX-23.1 - CONSENT OF MAYER HOFFMAN MCCANN PC - March 25, 2010

Attached files

file filename
10-K - FORM 10-K - Sorrento Therapeutics, Inc.d10k.htm
EX-31.1 - CERTIFICATION - Sorrento Therapeutics, Inc.dex311.htm
EX-32.1 - CERTIFICATION - Sorrento Therapeutics, Inc.dex321.htm
EX-31.2 - CERTIFICATION - Sorrento Therapeutics, Inc.dex312.htm
EX-10.6 - CONSULTING AGREEMENT - Sorrento Therapeutics, Inc.dex106.htm
EX-10.7 - EMPLOYMENT LETTER - Sorrento Therapeutics, Inc.dex107.htm
EX-10.10 - AMENDMENT #2 TO OFFICE LEASE - Sorrento Therapeutics, Inc.dex1010.htm
EX-10.17 - 2009 EQUITY INCENTIVE PLAN - Sorrento Therapeutics, Inc.dex1017.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in Registration Statement No. 333-163670 on Form S-8 of our report dated March 25, 2010, relating to the financial statements of Sorrento Therapeutics, Inc. for the year ended December 31, 2009, appearing in this Annual Report on Form 10-K of Sorrento Therapeutics, Inc.

/s/ Mayer Hoffman McCann P.C.

San Diego, California

March 25, 2010

Sorrento Therapeutics, Inc. Reports

Also read